Exobiosphere, Myriamed, and KIST-Europe’s ‘MyrSpaceCardio’ to Advance Cardiac Tissue Engineering in Space

Myriamed GmbH, KIST-Europe Forschungsgesellschaft mbH, and Exobiosphere have been selected for the European Space Agency Business in Space Growth Network …
Exobiosphere, Myriamed, and KIST-Europe’s ‘MyrSpaceCardio’ to Advance Cardiac Tissue Engineering in Space

Myriamed GmbH, KIST-Europe Forschungsgesellschaft mbH, and Exobiosphere have been selected for the European Space Agency Business in Space Growth Network (BSGN) Life Science Industry Accelerator with their joint project 'myrSpaceCardio’, a pioneering initiative to develop next-generation human cardiac tissue models in microgravity. The project addresses a major bottleneck in drug development and cardiac disease research.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
Picture of Joshua Faleti
Joshua Faleti
Kofoworola Joshua Faleti is the News Editor. He enjoys talking and learning about space and wants to talk about space to anyone who cares to listen. Joshua is interested in Space Law and Policy and how Space can positively impact human lives. Joshua is also a big music lover.
Continue Reading
Business Club - Thank You
SWGL FanShop
Join BusinessClub

Don't Miss Any Updates

NEWSLETTER

Subscribe now to receive the best of space insights directly in your inbox!

Free of charge, finished in just 20 seconds!

* Required
Email
Contact
Newsletter
Please select the newsletter of your choice *

Yes, I would like to receive the selected newsletters for free.

You can unsubscribe anytime via the link in our emails or by contacting us. We respect your information. For details, check our Privacy Policy.
By clicking below, you agree to our terms, in particular the transfer of data to Mailchimp.
.